Correlation Between Visa and Talis Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Talis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Talis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Talis Biomedical Corp, you can compare the effects of market volatilities on Visa and Talis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Talis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Talis Biomedical.

Diversification Opportunities for Visa and Talis Biomedical

-0.85
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Visa and Talis is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Talis Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talis Biomedical Corp and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Talis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talis Biomedical Corp has no effect on the direction of Visa i.e., Visa and Talis Biomedical go up and down completely randomly.

Pair Corralation between Visa and Talis Biomedical

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.12 times more return on investment than Talis Biomedical. However, Visa Class A is 8.17 times less risky than Talis Biomedical. It trades about 0.1 of its potential returns per unit of risk. Talis Biomedical Corp is currently generating about -0.07 per unit of risk. If you would invest  22,047  in Visa Class A on August 31, 2024 and sell it today you would earn a total of  9,461  from holding Visa Class A or generate 42.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy83.96%
ValuesDaily Returns

Visa Class A  vs.  Talis Biomedical Corp

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Talis Biomedical Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Visa and Talis Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Talis Biomedical

The main advantage of trading using opposite Visa and Talis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Talis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will offset losses from the drop in Talis Biomedical's long position.
The idea behind Visa Class A and Talis Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world